Emerging research suggest new MRI techniques may serve as a pivotal step toward improved treatment of brain disorders.
The new scans analyze tissue composition and structure allowing detection of early brain changes that may respond to intervention before permanent brain transformation.
A salient feature of the new examination technique is the capability to detect mild cognitive disorders (MCI), a condition in which patients suffer mild memory problems that is often an early symptom of Alzheimer’s disease (AD).
Results of the research were published in a recent issue of Neurobiology of Aging.
“This is important because detecting this kind of brain abnormality in its early stages with these techniques could have pivotal importance for the early detection and management of AD,” said lead author of the study Cristos Davatzikos, MD, Chief of the Biomedical Image Analysis Section in Penn’s Department of Radiology.
“The diagnostic power of this technique could work hand-in-hand with the new drugs currently under development that target the early stages of AD before irreversible brain tissue damage sets in.”
In the first-of-its-kind study, researchers created a unique picture of patients’ brains by combining and analyzing MRI images measuring the density and volume of various different tissues and their spatial distribution within the brain.
From these images patterns associated with MCI were detected. Using this technique, researchers were able to not only to detect, with 100 % accuracy, those patients in the study with cognitive impairment from those with normal cognitive function, but also those predicted, with 90 percent accuracy, those patients with increasing onset of MCI, thereby demonstrating the diagnostic power of the new tool.
The technique designed by the researchers provides, for the first time, the sensitivity and specificity for individual patient diagnosis of MCI leading to AD.
Not only are the abnormalities in the MCI brain detected earlier than other imaging techniques, but can be identified and measured even before the patient’s mental processes deteriorate to the point of clinical symptoms.
The ability to accurately classify even mildly impaired individuals from a single cross-sectional MRI is significant because it contrasts with prevailing thinking that effective prediction of early stages of AD will require measurement of longitudinal brain changes.
Frequent follow-up is often difficult and expensive in a clinical setting. This study demonstrated that an accurate diagnosis can be made from a single MRI image.
“Our study is the first to show that by using MRI techniques to classify tissue patterns in the brain provides very high diagnostic accuracy on an individual basis,” added Davatzikos.
Prevalence of AD doubles every 5 years of life after the age of 60, with more than four million Americans affected.
Definitive diagnosis requires postmortem identification of amyloid plaques and neurofibrillary tangles linked to the disease. Patients with MCI, which include memory problems that do not meet criteria for dementia, convert to AD with rates of 6 – 15 % annually.
This new method of analysis using MRI imaging to detect tissue patterns, promises to aid in the early diagnosis and monitoring of MCI and AD.